Geode Capital Management »

Apimeds Pharmaceuticals Us I shares owned by Geode Capital Management

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $55k 31k 1.78

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Inc-class A Shares Com Cl A (V)
Netflix (NFLX)
Mastercard Inc - A Cl A (MA)

View all positions for Geode Capital Management

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Renaissance Technologies
XTX Topco
Hrt Financial
Jpmorgan Chase & Co

View all funds holding Apimeds Pharmaceuticals Us I